According to CoinDesk, Glassnode data shows that Solana's recent 30-day realized market cap inflow has returned to positive growth, with an annualized growth rate of 4–5%. This marks the first positive turn after weeks of capital outflow, indicating initial signs of buyer pressure returning. Although prices have not yet significantly rebounded, this indicator is often seen as a potential precursor to a reversal, suggesting that the market may have completed a phase of "capitulation" clearing.
Funds on Solana Chain Turn Positive, Indicating Initial Signs of Market Confidence Recovery
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.
Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks
Goldman Sachs stated that the Japanese yen has become a better tool for hedging against AI shocks, with policy shifts reducing the risk of depreciation. The bank recommends shorting USD/JPY and EUR/JPY.

